There are many mechanisms at work here, but the blood sugar increase is probably secondary to the weight gain, rather than ...

I was wondering whether Ozempic might be prescribed for somebody who gained weight due to antipsychotics or drugs for depression. I read some years ago that the weight gain associated with ...

Antipsychotics are the best defense against relapse in schizophrenia, even though that protection often comes at the expense ...

DEAR DR. ROACH: I was wondering whether Ozempic might be prescribed for somebody who gained weight due to antipsychotics or ...

By big pharma standards, these were massive moves that in one fell swoop crowned Bristol-Myers the runaway leader in a ...

Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...

Hey guys. Thanks for taking my questions. First is on Auvelity curious your thoughts on new atypical antipsychotics that are likely to be approved next year. As adjunctive I get that these are ...

In a clinical setting where most service users are males, concerns over bodily changes such as gynaecomastia due to long term ...

Negative drug results cost AbbVie billions of dollars in market value and convinced analysts that Bristol Myers had placed a ...

Emraclidine was expected to be a competitor to Bristol Myers Squibb’s recently approved Cobenfy, but trial results put its ...

AbbVie said on Monday that an experimental schizophrenia drug it gained through an $8.7 billion deal for Cerevel Therapeutics failed two mid-stage studies, sending the drugmaker's shares plunging 12.5 ...

Shares in AbbVie slumped Monday after the company disclosed its psychiatric medicine emraclidine didn’t best placebo in two ...